BRAND: AirFluSal Forspiro
ACTIVE INGREDIENT: Salmeterol/Fluticasone
STRENGTH, PACK SIZE & GMS CODE:
50mcg/250mcg inhalation powder 1 x 60 doses ~ 53487
50mcg/500mcg inhalation powder 1 x 60 doses ~ 53488
AirFluSal® Forspiro® is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled with inhaled corticosteroids and as needed inhaled short acting β2 agonist or patients already adequately controlled on both inhaled corticosteroid and long-acting β2 agonist.
Chronic Obstructive Pulmonary Disease (COPD)
AirFluSal ® Forspiro® 50 microgram/500 microgram/dose is indicated for the symptomatic treatment of patients with COPD, with a FEV1